Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Xingqi tannikaer** is an oral Uyghur traditional-medicine capsule developed by Xinjiang Uygur Pharmaceutical for gastrointestinal symptoms and constipation. Public clinical-trial records include a completed Phase II study in functional constipation and a recruiting Phase III confirmatory study for decreased appetite, abdominal distension, and constipation associated with abnormal mucus temperament. Published quality-control work identifies borax, aloe, pepper, and henbane among the formulation's constituents. Its molecular pharmacology and specific biological targets have not been publicly established.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xingqi tannikaer.